BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Havervall S, Jernbom Falk A, Klingström J, Ng H, Greilert-Norin N, Gabrielsson L, Salomonsson AC, Isaksson E, Rudberg AS, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E, Christ W, Olausson M, Hedhammar M, Tegel H, Mangsbo S, Phillipson M, Månberg A, Hober S, Nilsson P, Thålin C. SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection. PLoS One 2022;17:e0262169. [PMID: 35020778 DOI: 10.1371/journal.pone.0262169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Djaïleb A, Lavallée É, Parker M, Cayer M, Desautels F, de Grandmont MJ, Stuible M, Gervais C, Durocher Y, Trottier S, Boudreau D, Masson J, Brouard D, Pelletier JN. Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordance. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1052424] [Reference Citation Analysis]
2 Lamb C, Owens C, Gamboa W, Lopez-Yunez A. Evaluating Johnson and Johnson COVID-19 Vaccination Outcomes in a Low-Income Hispanic Population. Vaccines (Basel) 2023;11. [PMID: 36679993 DOI: 10.3390/vaccines11010148] [Reference Citation Analysis]
3 Kongkamol C, Ingviya T, Chusri S, Surasombatpattana S, Kwanyuang A, Chaichulee S, Sophark I, Seesong C, Sorntavorn T, Detpreechakul T, Phaiboonpornpong P, Krainara K, Sathirapanya P, Sathirapanya C. Integrative Effects between a Bubble and Seal Program and Workers' Compliance to Health Advice on Successful COVID-19 Transmission Control in a Factory in Southern Thailand. Int J Environ Res Public Health 2022;19. [PMID: 36554271 DOI: 10.3390/ijerph192416391] [Reference Citation Analysis]
4 Yaugel-Novoa M, Bourlet T, Paul S. Role of the humoral immune response during COVID-19: guilty or not guilty? Mucosal Immunol 2022;15:1170-80. [PMID: 36195658 DOI: 10.1038/s41385-022-00569-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Coelho LE, Luz PM, Pires DC, Jalil EM, Perazzo H, Torres TS, Cardoso SW, Peixoto EM, Nazer S, Massad E, Silveira MF, Barros FC, Vasconcelos AT, Costa CA, Amancio RT, Villela DA, Pereira T, Goedert GT, Santos CV, Rodrigues NC, Grinsztejn B, Veloso VG, Struchiner CJ. Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey. The Lancet Regional Health - Americas 2022;15:100338. [DOI: 10.1016/j.lana.2022.100338] [Reference Citation Analysis]
6 Silva MJA, Ribeiro LR, Lima KVB, Lima LNGC. Adaptive immunity to SARS-CoV-2 infection: A systematic review. Front Immunol 2022;13:1001198. [DOI: 10.3389/fimmu.2022.1001198] [Reference Citation Analysis]
7 Friedman SM, Li J, Thomas P, Gurumurthy M, Siderits R, Nepomich A, Lifshitz E. Neutralizing Antibody Responses Among Residents and Staff of Long-Term Care Facilities in the State of New Jersey During the First Wave of the COVID-19 Pandemic. J Community Health 2022. [PMID: 36197535 DOI: 10.1007/s10900-022-01142-z] [Reference Citation Analysis]
8 Mancuso R, Agostini S, Citterio LA, Chiarini D, Santangelo MA, Clerici M. Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines. Vaccines (Basel) 2022;10:1649. [PMID: 36298514 DOI: 10.3390/vaccines10101649] [Reference Citation Analysis]
9 Brlić PK, Pavletić M, Lerga M, Krstanović F, Matešić MP, Miklić K, Malić S, Mikša L, Pajcur M, Peruč D, Schubert M, Bertoglio F, Arapović J, Protić A, Šustić A, Milošević M, Šain LČ, Jonjić S, Lisnić VJ, Brizić I. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study. Viruses 2022;14:1966. [PMID: 36146773 DOI: 10.3390/v14091966] [Reference Citation Analysis]
10 Sarjomaa M, Diep LM, Zhang C, Tveten Y, Reiso H, Thilesen C, Nordbø SA, Berg KK, Aaberge I, Pearce N, Kersten H, Vandenbroucke JP, Eikeland R, Fell AKM. SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway. PLoS ONE 2022;17:e0264667. [DOI: 10.1371/journal.pone.0264667] [Reference Citation Analysis]
11 Ding J, Liu C, Wang Z, Guo H, Zhang K, Ma L, Wang B, Zhao H, Song M, Guan X. Characteristics and Prognosis of Antibody Non-responders With Coronavirus Disease 2019. Front Med 2022;9:813820. [DOI: 10.3389/fmed.2022.813820] [Reference Citation Analysis]
12 Texis T, Luis Cruz-jaramilllo J, García-muñoz W, Anzures-cortés L, Haddad-talancón L, Sánchez-garcía S, del Carmen Jiménez Martínez M, Pérez Barragán E, Nieto-patlán A, Martínez-ezquerro JD, Rubio-carrasco K, Rodríguez-dorantes M, Cortés-ramírez S, Mellado-sánchez G, Pérez-tapia SM, Gonzalez-covarrubias V. COVID-19 relevant genetic variants confirmed in an admixed population.. [DOI: 10.1101/2022.04.15.22273925] [Reference Citation Analysis]
13 Bar-On L, Aftalion M, Makdasi E, Gur D, Alcalay R, Cohen H, Beth-Din A, Rosenfeld R, Achdout H, Bar-Haim E, Falach R, Chitlaru T, Cohen O. Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice. Vaccines (Basel) 2022;10:613. [PMID: 35455362 DOI: 10.3390/vaccines10040613] [Reference Citation Analysis]
14 Laurén I, Havervall S, Ng H, Lord M, Pettke A, Greilert-Norin N, Gabrielsson L, Chourlia A, Amoêdo-Leite C, Josyula VS, Eltahir M, Kerzeli I, Falk AJ, Hober J, Christ W, Wiberg A, Hedhammar M, Tegel H, Burman J, Xu F, Pin E, Månberg A, Klingström J, Christoffersson G, Hober S, Nilsson P, Philipson M, Dönnes P, Lindsay R, Thålin C, Mangsbo S. Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology. Immun Inflamm Dis 2022;10:e595. [PMID: 35349756 DOI: 10.1002/iid3.595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Jotschke S, Schulze S, Jaekel N, Ludwig-kraus B, Engelmann R, Kraus FB, Zahn C, Nedlitz N, Prange-krex G, Mohm J, Peuser B, Schwarz M, Spohn C, Behlendorf T, Binder M, Junghanss C, Böttcher S, Al-ali HK. Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO). Cancers 2022;14:1544. [DOI: 10.3390/cancers14061544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sarjomaa M, Diep LM, Zhang C, Tveten Y, Reiso H, Thilesen C, Nordbø SA, Berg KK, Aaberge I, Pearce N, Kersten H, Vandenbroucke JP, Eikeland R, Møller Fell AK. SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway.. [DOI: 10.1101/2022.02.16.22271075] [Reference Citation Analysis]
17 Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-kanamori L, Islam N, Al-shebly R, Shalaby R, Habibullah M, Al-marwani TA, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis. Pathogens and Global Health. [DOI: 10.1080/20477724.2022.2029301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]